Prostate cancer trials in China

In China 252 Also abroad 1489

40 of 252 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making
Where
Shanghai
Age
55 years and over
People
90
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07856017
No phaseNot yet taking people in China
CascadeDiagnose Prostate MRI
Where
Guigang, Guilin, Liuzhou, Nanning, Wuzhou
Age
18 years and over
People
3,000
Run by
First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT07844304
No phaseEnrolling by invitation
Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT
Where
Beijing, Guangzhou, Jinan, Shanghai
Age
18 years and over
People
1,500 worldwide
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07690306
No phaseNot yet taking people in China
Spatial Multi-Omics of Perineural Invasion Microenvironment and Prognosis in Prostate Cancer
Where
Hefei
Age
18 years to 85 years
People
120
Run by
Anhui Medical University
See details and how to joinNCT07818395
No phaseNot yet taking people in China
Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer
Where
Hefei
Age
18 years and over
People
100
Run by
Anhui Medical University
See details and how to joinNCT07818421
No phaseTaking people
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
Where
Hefei, Qingdao, Tianjin
Age
18 years to 80 years
People
500
Run by
Tianjin Medical University
See details and how to joinNCT06690970
No phaseTaking people
Adjuvant Chemotherapy for High Malignant Prostate Cancer
Where
Baoding, Beijing, Shenzhen
Age
18 years to 80 years
People
315
Run by
Peking University First Hospital
See details and how to joinNCT06864533
No phaseTaking people
An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
Where
Multiple Locations
Age
18 years and over
People
800
Run by
Bayer
See details and how to joinNCT07538843
No phaseTaking people
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients
Where
Shanghai
Age
18 years to 75 years
People
50
Run by
RenJi Hospital
See details and how to joinNCT06469710
No phaseTaking people
miRNA Panel for PCa Diagnosis
Where
Shanghai
Age
18 years and over
People
500
Run by
RenJi Hospital
See details and how to joinNCT07755592
No phaseTaking people
Development of an AI-Agent for Urological Disease Diagnosis and Treatment
Where
Ganzhou, Guangzhou, Shantou
People
2,000
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07721935
No phaseTaking people
Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports
Where
Wenzhou
Age
18 years and over
People
4,600
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07707232
No phaseTaking people
MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology
Where
Taizhou
Age
15 years to 90 years
People
80
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07694752
No phaseNot yet taking people in China
Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery
Where
Changsha
Age
18 years and over
People
120
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07690462
No phaseEnrolling by invitation
AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology
Where
Changsha
Age
18 years to 90 years
People
3,000
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07660276
No phaseTaking people
Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
Where
Liuzhou
Age
40 years to 90 years
People
3,000
Run by
Guangxi Medical University
See details and how to joinNCT07614256
No phaseTaking people
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT07553754
No phaseTaking people
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
110
Run by
Xijing Hospital
See details and how to joinNCT07553780
No phaseTaking people
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
Where
Suzhou
Age
20 years to 90 years
People
300
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07552285
No phaseTaking people
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT07531329
No phaseTaking people
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
Where
Shanghai
Age
18 years to 99 years
People
170
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07290270
No phaseTaking people
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,700 worldwide
Run by
Xijing Hospital
See details and how to joinNCT07492927
No phaseTaking people
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years to 100 years
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT07474142
No phaseTaking people
The Development and Validation of MRI-AI-based Predictive Models for csPCa
Where
Beijing
People
3,000
Run by
Peking University First Hospital
See details and how to joinNCT06842264
No phaseNot yet taking people in China
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Where
Guangzhou
Age
18 years and over
People
150
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07376057